...
机译:凝血酶原复合物浓缩至颅内出血患者的逆转Warfarin诱导的凝结病变
Albany College of Pharmacy Department of Pharmacy Practice United States;
Maine Medical Center Department of Pharmacy United States Maine Medical Center Department of;
Maine Medical Center Department of Critical Care Services United States;
University of Vermont School of Medicine Department of Surgery United States;
Maine Medical Center Blood Bank United States;
Maine Medical Center Neuroscience Institute United States University of Vermont School of;
Maine Medical Center Blood Bank United States Maine Medical Center Neuroscience Institute;
Coagulopathy; Hematoma expansion; Intracerebral hemorrhage; Oral anticoagulation therapy; Subarachnoid hemorrhage; Subdural hematoma; Traumatic brain injury;
机译:凝血酶原复合物浓缩至颅内出血患者的逆转Warfarin诱导的凝结病变
机译:激活的凝血酶原复合物浓缩因子VIII抑制剂绕过活性(FEIBA)用于逆转华法林诱发的凝血病
机译:凝血酶原复合物浓缩物与严重凝血病或活动性出血患者的死亡和血栓栓塞并发症相关
机译:在肝脏移植患者中的内塞牙科植入物,具有与免疫抑制治疗和颅内出血相关的神经系统损伤:案例报告
机译:逆转华法林相关凝血病:凝血酶原浓缩物与颅内出血患者的老年患者新鲜冷冻血浆
机译:凝血酶原复合物浓缩物用于华法林引起的机械性主动脉瓣出血
机译:激活的凝血酶原复合物浓缩因子VIII抑制剂绕过活性(FEIBA)用于逆转华法林诱发的凝血病